Switch theme
Sign up to access all valuation multiples
Jiangsu Yuyue Medical Equipment And Supply Co Ltd is engaged in providing household medical devices, medical clinical products, and related medical services, R&D, manufacturing and sales of medical device products, and providing related solutions. The company's products are mainly focused on respiratory oxygen production, diabetes care, infection control solutions, household electronic testing and in vitro diagnostics, first aid, and clinical and rehabilitation devices.
2007
6.1K+
LTM Revenue $1.2B
LTM EBITDA $335M
$3.9B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Jiangsu Yuyue Medical has a last 12-month revenue of $1.2B and a last 12-month EBITDA of $335M.
In the most recent fiscal year, Jiangsu Yuyue Medical achieved revenue of $1.1B and an EBITDA of $433M.
Jiangsu Yuyue Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Jiangsu Yuyue Medical valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $1.1B | $1.1B | XXX | XXX | XXX |
| Gross Profit | $459M | $471M | XXX | XXX | XXX |
| Gross Margin | 42% | 42% | XXX | XXX | XXX |
| EBITDA | $433M | $321M | XXX | XXX | XXX |
| EBITDA Margin | 39% | 29% | XXX | XXX | XXX |
| Net Profit | $204M | $220M | XXX | XXX | XXX |
| Net Margin | 19% | 20% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Jiangsu Yuyue Medical's stock price is CNY 35 (or $5).
Jiangsu Yuyue Medical has current market cap of CNY 34.7B (or $4.8B), and EV of CNY 28.1B (or $3.9B).
See Jiangsu Yuyue Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3.9B | $4.8B | XXX | XXX | XXX | XXX | $0.28 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Jiangsu Yuyue Medical has market cap of $4.8B and EV of $3.9B.
Jiangsu Yuyue Medical's trades at 3.3x LTM EV/Revenue multiple, and 11.5x LTM EBITDA.
Analysts estimate Jiangsu Yuyue Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Jiangsu Yuyue Medical and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $3.9B | XXX | XXX | XXX |
| EV/Revenue | 3.5x | XXX | XXX | XXX |
| EV/EBITDA | 12.1x | XXX | XXX | XXX |
| P/E | 17.6x | XXX | XXX | XXX |
| P/E/Growth | 1.1x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpJiangsu Yuyue Medical's NTM/LTM revenue growth is 13%
Jiangsu Yuyue Medical's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $45K for the same period.
Over next 12 months, Jiangsu Yuyue Medical's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Jiangsu Yuyue Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Jiangsu Yuyue Medical and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 1% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 29% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -26% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 42% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
| Opex per Employee | $45K | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 9% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 6% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 25% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Jiangsu Yuyue Medical acquired XXX companies to date.
Last acquisition by Jiangsu Yuyue Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Jiangsu Yuyue Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Jiangsu Yuyue Medical founded? | Jiangsu Yuyue Medical was founded in 2007. |
| Where is Jiangsu Yuyue Medical headquartered? | Jiangsu Yuyue Medical is headquartered in China. |
| How many employees does Jiangsu Yuyue Medical have? | As of today, Jiangsu Yuyue Medical has 6.1K+ employees. |
| Is Jiangsu Yuyue Medical publicy listed? | Yes, Jiangsu Yuyue Medical is a public company listed on SHE. |
| What is the stock symbol of Jiangsu Yuyue Medical? | Jiangsu Yuyue Medical trades under 002223 ticker. |
| When did Jiangsu Yuyue Medical go public? | Jiangsu Yuyue Medical went public in 2008. |
| Who are competitors of Jiangsu Yuyue Medical? | Similar companies to Jiangsu Yuyue Medical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Jiangsu Yuyue Medical? | Jiangsu Yuyue Medical's current market cap is $4.8B |
| What is the current revenue of Jiangsu Yuyue Medical? | Jiangsu Yuyue Medical's last 12-month revenue is $1.2B. |
| What is the current EBITDA of Jiangsu Yuyue Medical? | Jiangsu Yuyue Medical's last 12-month EBITDA is $335M. |
| What is the current EV/Revenue multiple of Jiangsu Yuyue Medical? | Current revenue multiple of Jiangsu Yuyue Medical is 3.3x. |
| What is the current EV/EBITDA multiple of Jiangsu Yuyue Medical? | Current EBITDA multiple of Jiangsu Yuyue Medical is 11.5x. |
| What is the current revenue growth of Jiangsu Yuyue Medical? | Jiangsu Yuyue Medical revenue growth between 2023 and 2024 was 1%. |
| Is Jiangsu Yuyue Medical profitable? | Yes, Jiangsu Yuyue Medical is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
